PARAMETRIC PORTFOLIO ASSOCIATES LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$455,000
+15.8%
2,098
-38.4%
0.00%
Q4 2020$393,000
+10.4%
3,408
-6.9%
0.00%
Q3 2020$356,000
-94.0%
3,662
-92.5%
0.00%
-100.0%
Q2 2020$5,972,000
+8.0%
48,664
-22.9%
0.01%0.0%
Q1 2020$5,530,000
+14.7%
63,152
+37.0%
0.01%
+25.0%
Q4 2019$4,820,000
+10.2%
46,095
+21.2%
0.00%0.0%
Q3 2019$4,375,000
+375.5%
38,036
+612.4%
0.00%
+300.0%
Q2 2019$920,000
+11.2%
5,339
+8.8%
0.00%0.0%
Q1 2019$827,000
+72.3%
4,907
-0.3%
0.00%
Q4 2018$480,000
-37.2%
4,924
+11.4%
0.00%
-100.0%
Q3 2018$764,000
+53.1%
4,422
+23.6%
0.00%
Q2 2018$499,000
+31.0%
3,579
+5.8%
0.00%
Q1 2018$381,000
-15.0%
3,384
-0.3%
0.00%
Q4 2017$448,000
+28.4%
3,393
-1.2%
0.00%
Q3 2017$349,000
+2.6%
3,434
+1.1%
0.00%
Q2 2017$340,000
-45.2%
3,395
-33.8%
0.00%
-100.0%
Q1 2017$621,000
+31.3%
5,132
+21.4%
0.00%0.0%
Q4 2016$473,000
-52.3%
4,229
-43.4%
0.00%0.0%
Q3 2016$991,000
-16.5%
7,470
-42.4%
0.00%
-50.0%
Q2 2016$1,187,000
+143.7%
12,963
+92.1%
0.00%
+100.0%
Q1 2016$487,000
+110.8%
6,747
+102.7%
0.00%
Q4 2015$231,000
-24.0%
3,3280.0%0.00%
-100.0%
Q3 2015$304,000
-25.7%
3,3280.0%0.00%0.0%
Q2 2015$409,000
+35.0%
3,3280.0%0.00%0.0%
Q1 2015$303,000
+34.7%
3,3280.0%0.00%
Q4 2014$225,0003,3280.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders